Tristel PLC Result of AGM

RNS Number : 2739Q

Tristel PLC

16 December 2024

 

TRISTEL plc

("Tristel" or the "Company")

 

Result of AGM

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

 

The results of the AGM will be made available on the Company's website: https://investors.tristel.com/investor-hub/

 

The Company confirms that in relation to Resolution 6, the performance targets for the initial long-term incentive plan (LTIP) awards will be 50% based on earning per share (EPS) targets and 50% based on relative total shareholder return (TSR) versus the constituents of the AIM 100 as at the grant of the awards as follows:

 

50% of Initial awards		50% of Initial awards
EPS FY 26/27	% of EPS Part that Vests	Relative TSR measured over 3 years from grant	% of TSR Part that Vests
Less than 18p	0%	Below median	0%
Between 18p and 25p	Pro-rata 25% to 100%	Between median and upper quartile	Pro-rata 25% to 100%
25p or better	100%	Upper quartile or above	100%

 

 

 

For further information please contact:

 

Tristel plc		Via Walbrook PR
Matt Sassone, Chief Executive Officer		www.investors.tristel.com
Liz Dixon, Chief Financial Officer
Walbrook PR Ltd		Tel: [phone] or [e-mail]
Paul McManus / Lianne Applegarth / Alice Woodings	Mob: [phone]
Cavendish Capital Markets Ltd		Tel: [phone]
Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance)
Sunila de Silva (ECM) / Louise Talbot (Sales)

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO₂) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit: https://tristel.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

RAGFLFSSFSLRLIS